Total Payments
$4,094
2024 Payments
$2,202
Companies
19
Transactions
232
Medicare Patients
375
Medicare Billing
$36,754
Payment Breakdown by Category
Food & Beverage$4,094 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,094 | 232 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $598.89 | 36 | $0 (2024) |
| Alkermes, Inc. | $387.60 | 23 | $0 (2024) |
| Axsome Therapeutics, Inc. | $320.64 | 16 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $316.90 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $301.98 | 23 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $295.21 | 8 | $0 (2024) |
| Corium, LLC | $282.68 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $250.41 | 14 | $0 (2024) |
| Almatica Pharma LLC | $234.53 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $231.25 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,202 | 122 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($316.90) |
| 2023 | $1,566 | 92 | ABBVIE INC. ($299.62) |
| 2022 | $264.61 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($63.93) |
| 2021 | $37.17 | 2 | Sunovion Pharmaceuticals Inc. ($23.25) |
| 2019 | $24.04 | 2 | Ironshore Pharmaceuticals Inc. ($24.04) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.56 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/26/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $17.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $42.52 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/01/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: CNS | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 135 | 245 | $20,695 | $12,392 |
| 2022 | 3 | 67 | 117 | $9,658 | $7,067 |
| 2021 | 3 | 38 | 105 | $11,180 | $7,324 |
| 2020 | 4 | 135 | 295 | $27,612 | $9,971 |
Total Patients
375
Total Services
762
Medicare Billing
$36,754
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 136 | $11,428 | $6,788 | 59.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 74 | $4,805 | $2,569 | 53.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 20 | 20 | $2,923 | $2,278 | 77.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 15 | $1,540 | $756.22 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 75 | $5,894 | $4,327 | 73.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 18 | 18 | $2,536 | $1,897 | 74.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 24 | $1,227 | $843.53 | 68.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 46 | $4,830 | $3,101 | 64.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 14 | 48 | $4,800 | $2,983 | 62.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 11 | 11 | $1,550 | $1,240 | 80.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 42 | 97 | $8,148 | $3,558 | 43.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 102 | $8,568 | $2,833 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 26 | 68 | $5,712 | $2,235 | 39.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 15 | $3,000 | $786.88 | 26.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 11 | 13 | $2,184 | $558.36 | 25.6% |
About Dr. Stuart Larson, MD
Dr. Stuart Larson, MD is a Psychiatry healthcare provider based in Danville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124178009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Larson, MD has received a total of $4,094 in payments from pharmaceutical and medical device companies, with $2,202 received in 2024. These payments were reported across 232 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,094).
As a Medicare-enrolled provider, Larson has provided services to 375 Medicare beneficiaries, totaling 762 services with total Medicare billing of $36,754. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Danville, KY
- Active Since 01/11/2007
- Last Updated 02/28/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1124178009
Products in Payments
- VRAYLAR (Drug) $598.89
- CAPLYTA (Drug) $499.75
- REXULTI (Drug) $336.38
- Auvelity (Drug) $320.64
- Azstarys (Drug) $282.68
- LYBALVI (Drug) $278.95
- TRINTELLIX (Drug) $250.41
- Qelbree (Drug) $237.06
- LOREEV XR (Drug) $234.53
- INVEGA SUSTENNA (Drug) $231.25
- FANAPT (Drug) $146.65
- INGREZZA (Drug) $115.67
- ARISTADA (Drug) $90.32
- COBENFY (Drug) $83.03
- LATUDA (Drug) $77.55
- ABILIFY MAINTENA (Drug) $62.04
- QELBREE (Drug) $58.15
- Austedo XR (Drug) $45.39
- QUVIVIQ (Drug) $41.63
- AUSTEDO (Drug) $29.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Danville
Dr. Douglas Mulinix, Md, MD
Psychiatry — Payments: $24,434
Psychiatry $24,434
Kanchan Clark, Md, MD
Psychiatry — Payments: $13,331
Psychiatry $13,331
Donovan Clark, Md, MD
Psychiatry — Payments: $12,563
Psychiatry $12,563
Dr. Ameek Mundi, D.o, D.O
Psychiatry — Payments: $10,638
Psychiatry $10,638
Dr. Robert Gerstman, D.o, D.O
Psychiatry — Payments: $5,786
Psychiatry $5,786
Dr. William Trost, M.d, M.D
Psychiatry — Payments: $1,972
Psychiatry $1,972